Wendy DiCicco

Wendy DiCicco is an experienced C-suite executive and corporate director with an array of corporate leadership accomplishments for both public and private companies. She currently is a Board Director of EyePoint Pharmaceuticals—also serving as Audit Committee Chair—and Carmell Therapeutics. She previously served on three public and private boards in the medical device, semiconductor and biotechnology sectors, chairing audit, compensation, and governance committees. Ms. DiCicco is a financial, executive and board advisory consultant for emerging growth companies, often as interim CFO. She previously was COO & CFO of Centinel Spine, President & COO of Camber Spine Technologies, and CFO for several medical device and biotechnology companies, including 12 years at Kensey Nash Corporation. Ms. DiCicco started her career with Deloitte & Touche in audit assurance. In the community, she is on the boards of the Chester County Library System and the Philadelphia Chapter of the National Association of Corporate Directors, where she is also a Corporate Governance and Board Leadership Fellow. Ms. DiCicco graduated from Philadelphia College of Textiles and Science with a B.S. degree in Accounting and is a CPA.